FDA Funding Helped By Ebola Emergency Spending, But Opioid Issue Still Rankles Appropriators
This article was originally published in RPM Report
Executive Summary
Spending agreement includes $137 more for FDA—most from user fee increases previously enacted. Still, discretionary budget does go up for FDA, albeit at the cost of a rider demanding final action on abuse-deterrent formulation guidance by June.